Cancer Cause and Prevention Research

Open opportunities

• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  Cancer Cause and Prevention Research · Posted 2023-12-15 · Deadline 2027-01-07 · NAICS 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  Cancer Cause and Prevention Research · Posted 2023-12-15 · Deadline 2027-01-07 · NAICS 621511 - Medical Laboratories
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  Cancer Cause and Prevention Research · Posted 2023-12-15 · Deadline 2027-01-07 · NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  Cancer Cause and Prevention Research · Posted 2023-12-15 · Deadline 2027-01-07 · NAICS 541380 - Testing Laboratories and Services
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  Cancer Cause and Prevention Research · Posted 2023-12-15 · Deadline 2027-01-07
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  Cancer Cause and Prevention Research · Posted 2023-08-24 · Deadline 2027-01-07 · NAICS 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  Cancer Cause and Prevention Research · Posted 2023-08-24 · Deadline 2027-01-07 · NAICS 621511 - Medical Laboratories
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  Cancer Cause and Prevention Research · Posted 2023-08-24 · Deadline 2027-01-07 · NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  Cancer Cause and Prevention Research · Posted 2023-08-24 · Deadline 2027-01-07 · NAICS 541380 - Testing Laboratories and Services
• Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
  Cancer Cause and Prevention Research · Posted 2023-08-24 · Deadline 2027-01-07